The Original Mammotome® Breast Biopsy System
As the world-wide leader in vacuum-assisted breast biopsy and tissue marking, Mammotome is committed to advancing technology for early detection of breast cancer.
The Mammotome® Biopsy System was the first vacuum-assisted biopsy device on the market, and is also the most clinically acclaimed. The key clinical proof is the more than 4 million patients who have undergone a biopsy with the Mammotome® biopsy system, and the 280+ clinical articles published on its efficacy. Our system empowers physicians to offer a more accurate diagnosis without the complications of an open surgical biopsy; maximizes tissue quality and diagnosis accuracy; and keeps up with the changing needs of physicians and patients with a software-driven and upgradeable system.
Mammotome's breakthrough computer-controlled vacuum system that keeps openings in the aperture and vacuum lines clear, virtually eliminating "dry taps".
Use of a single incision, single insertion, and single probe makes the Mammotome® Biopsy System a reliable diagnostic alternative to open surgical biopsy.
The Mammotome® Biopsy System enables biopsies to be performed less invasively under multiple platforms utilizing the same control module:
+ Original Mammotome® ST Stereotactic (x-ray) Imaging
+ Original Mammotome® EX Ultrasound Imaging
+ Original Mammotome® MR Magnetic Resonance Imaging (MRI)
+ Original Mammotome® MI for Molecular Imaging (MI)